Reuters logo
BRIEF-Beigene says announced dosing of first patient in a phase I clinical trial of BGB-290
December 21, 2016 / 10:34 PM / 9 months ago

BRIEF-Beigene says announced dosing of first patient in a phase I clinical trial of BGB-290

Dec 21 (Reuters) - Beigene Ltd :

* Says announced dosing of first patient in a phase I clinical trial of BGB-290 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below